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Abstract
Nipah virus (NiV), a zoonotic paramyxovirus, is highly contagious in swine, and can cause fatal infections in humans
following transmission from the swine host. The main viral targets in both species are the respiratory and central nervous
systems, with viremia implicated as a mode of dissemination of NiV throughout the host. The presented work focused on
the role of peripheral blood mononuclear cells (PBMC) in the viremic spread of the virus in the swine host. B lymphocytes,
CD42CD82, as well as CD4+CD82 T lymphocytes were not permissive to NiV, and expansion of the CD4+CD82 cells early
post infection was consistent with functional humoral response to NiV infection observed in swine. In contrast, significant
drop in the CD4+CD82 T cell frequency was observed in piglets which succumbed to the experimental infection,
supporting the hypothesis that antibody development is the critical component of the protective immune response.
Productive viral replication was detected in monocytes, CD6+CD8+ T lymphocytes and NK cells by recovery of infectious
virus in the cell supernatants. Virus replication was supported by detection of the structural N and the non-structural C
proteins or by detection of genomic RNA increase in the infected cells. Infection of T cells carrying CD6 marker, a strong
ligand for the activated leukocyte cell adhesion molecule ALCAM (CD166) highly expressed on the microvascular
endothelial cell of the blood-air and the blood-brain barrier may explain NiV preferential tropism for small blood vessels of
the lung and brain.
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Introduction
Nipah virus is a zoonotic, highly pathogenic, biosafety level 4
(BSL4) virus within the family Paramyxoviridae, genus Henipavirus [1].
Humans infected with NiV suffer primarily from severe encephalitis
with pulmonary involvement in high percentage of patients, and
with fatal outcome in about 40 or more percent of laboratory
confirmed cases, depending on the outbreak [2,3]. All human cases
during the initial 1998–1999 outbreak in Malaysia and Singapore
were due to transmission of NiV from infected pigs [4,5]. In
Bangladesh, transmission of the virus from its natural reservoir the
Pteropus bats to humans is by ingestion of contaminated date palm
sap or fruit. Only one cluster of cases was thought to be due to
transmission from pigs. In addition, nosocomial and human to
human transmission were also reported [6].
Better understanding of the NiV infection in swine would be
critical fordeveloping controlmeasures, shouldanother NiV disease
outbreak initiate in swine. Although infection ratio in affected swine
herds approached in the Malaysian outbreak 100%, morbidity
varied based on age, and mortality rate was rather low (1–5%). The
disease in pigs was mainly respiratory with involvement of a central
nervous system in some animals [5]. Suspected viremic dissemina-
tion of NiV throughout the swine host was confirmed during the
experimental infections of pigs [7]. The low level viremia is both,
cell free and cell associated. Involvement of the immune cells was
suggested by virus RNA detection in peripheral blood mononuclear
cells (PBMC) of NiV infected pigs, and by positive staining for NiV
antigen in lymphocytes and mononuclear cells within lymph nodes
and spleen, accompanied by lymphocyte necrosis and later in the
infection also by lymphoid depletion in the lymph nodes [8,9,10]. In
vitro infection of PBMC showed that NiV antigen was present in
monocytes and a subpopulation of lymphocytes [10]. NiV antigen
was also detected in infiltrating lymphocytes and monocytes of the
perivascular cuffs in brain and respiratory system, although to a
lower extent then in the endothelial cells of small blood vessels [9].
Infection and damage of the endothelial cells of small blood vessels,
associated with vasculitis, is an important feature of NiV infection in
susceptiblespecies [11].Interestingly,infectionoflargebloodvessels
was not detected.
Clinical outcome of Nipah virus infection in experimentally
inoculatedpigs (commercial Landracecrossbreed)somewhatdiffers
from thedisease observed inthe field inMalaysia.Theinfection isin
majority of pigs asymptomatic or with mild respiratory signs
compared to naturally infected pigs. However the nasal, oro-nasal
or subcutaneous inoculations lead in more animals to severe central
nervous signs compared to the field reports [7,9,10,12]. In the
nasally or oro-nasally infected piglets, NiV invades the central
nervous system (CNS) directly from the oronasal cavity via cranial
nerves, and by crossing the blood-brain barrier following viremic
spread [9,11]. In our attempts to produce positive control immune
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infected with NiV survived until 4 weeks post infection, indicating
35% mortality rate in this experimental model. Four of the
euthanized piglets, had not only NiV in the cerebrospinal fluid
(CSF), but also bacteria considered to be associated with immune-
compromised state (Enterococcus faecalis, Streptococcus suis) ([10]
unpublished data). It appears that infection of pigs with NiV may
predispose some of the pigs, possibly depending on the genetic
variability in MHC (SLA I and SLA II), T cell receptors or cytokine
genes [13] to secondary bacterial infections.
The aim of this study was to confirm the cell associated viremic
spread of NiV in porcine host by determining permissibility of
individual subpopulations of PBMC to the virus, and to determine
possible additional effects on cells of immune system present in
peripheral blood of the porcine host. The primary focus of the in
vivo work was the early stage post infection (up to 7 dpi) to better
understand mechanisms involved in pathogenesis of NiV in
porcine host during the acute phase of the disease.
Results
Viremia was implicated as a mode of dissemination of NiV
throughout the host, including swine [7,9,14]. In order to
determine the role of cells in the viremic spread of the virus,
and permissiveness of porcine immune cells to Nipah virus, the
work was initiated using PBMC. Due to constraints of work in
BSL4 containment, selection and combinations of markers/
antibodies had to be limited to maximum triple staining when
internal staining for viral antigen was employed, and to only
double staining for the cell surface markers.
NiV infection of porcine PBMC subpopulations in vitro
PBMC from non-infected pigs were separated into subpopula-
tions prior to the inoculation. After adhering the monocytes to a
cell culture plate, the non-adherent cells were sorted using
magnetic beads coated with antibodies against CD16 (NK cells),
CD6 (T lymphocytes), or CD21 (B lymphocytes) (Figure 1.A).
The purity of NK, T, and B cells was verified by flow cytometry
using the above markers. The T cells had the highest purity (90–
95%), followed by NK cells (85%), whereas purity of B cells was
the lowest in the range of 75–85%. The PBMC were alternatively
sorted using CD3 marker and CD4 or CD8 markers, as this
increased the purity of the T cell preparations in the double
antibody sorting with the resulting purity around 95%. Initially
CD6 marker was tested, but it appears that there was interference
in binding between the anti-CD6 and the anti-CD4 or anti-CD8
antibodies. Sorted cells were inoculated with NiV in non-
stimulated state, and for some of the cell preparations also after
stimulation with PMA combined with ionomycin to approximate
activated immune system post infection.
Replication of NiV in the individual subsets of cells was
determined by detection of infectious virus particles in supernatant
harvested from monocytes, NK and T lymphocytes. The
multiplicity of infection (moi) in these experiments was based on
NiV infectivity in Vero 76 cells to ascertain that the same
concentration of infectious particles was used for inoculation of all
cell preparations. The titre of the same NiV stock can be very
different when titrated on Vero 76 cells and on immortalized
alveolar macrophages (IPAM): 4610
6 and 5610
4 pfu/ml, respec-
tively. Consequently, it was expected that actual moi can be as low
as 0.001 (for example on monocytes).
At 48 hrs, the highest virus yield was detected in supernatants
harvested from monocytes (Figure 2.A). Very low level of
infectivity recovered from the B cells was likely due to
contaminating cells from other permissive subpopulations of
PBMC (about 25–30%). Stimulation of cells did not significantly
change the virus yield obtained in their supernatants, and was not
used in follow up experiments.
At 24 hrs post inoculation, the highest infectivity was recovered
from supernatants of the CD3+CD8+ sorted T lymphocytes
(Figure 2.B). Lower yield of virus was recovered from the CD6+
T lymphocytes and the CD4+ T lymphocytes, corresponding with
the observation that only lymphocytes carrying CD8+ marker
were permissive to NiV infection (see flow cytometry results
below). Interestingly, no infectivity was recovered from monocyte
supernatants at 24 hrs post inoculation (Figure 2.C). The finding
was supported by detection of NiV genomic RNA at different time
points post inoculation. The amount of genomic RNA dropped at
24 hrs, and then significantly increased at 48 hrs post infection
(Figure 2.D), while genomic RNA of gamma-irradiated NiV was
gradually decreasing below detectable level by 48 hrs post
exposure. Due to phagocytic nature of monocytes, most of the
virions are likely digested or processed for antigen presentation,
and only small number of infectious virions is able to initiate
productive infection in these cells.
Expression of one of the NiV receptors, ephrin-B2 was
determined to assess whether the block for virus replication could
be at the level of virus attachment. In resting state, all T
lymphocytes expressed ephrin-B2 mRNA, whether they were
permissive to NiV or not (Table 1). On the other hand,
monocytes and NK lymphocytes were permissive to NiV infection
in resting state without expressing the mRNA of ephrin- B2, and
started to express the mRNA upon stimulation and/or NiV
infection. While stimulation of the B lymphocytes with PMA/
ionomycin lead to ephrin-B2 expression, it did not render the cells
permissive to NiV.
Infection of T lymphocytes with NiV
Infection of T cells with NiV was supported by internal positive
staining for the NiV-N protein in the CD6+ sorted cells as
analyzed by flow cytometry, and in the CD3+CD8+ sorted cells by
positive staining for the non-structural C protein (Figure 3). NiV
Figure 1. Flow chart of sorting and staining of PBMC. Sorting of
cell subpopulations from peripheral blood mononuclear cells (PBMC) by
magnetic beads coated with antibodies against selected markers
(Fig. 1A), and staining of PBMC for CD4 and CD8 markers for analysis
by flow cytometry (Fig. 1B). (
hi) indicates high density expression of a
specific marker, and (
lo) indicates low density expression.
doi:10.1371/journal.pone.0030855.g001
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48 hrs post inoculation at 0.1 moi. NiV C protein was detected in
about 10% of the CD3+CD8+ T lymphocytes at 24 hrs post
inoculation, and reached 30% at 48 hrs. The intensity of staining
cannot be directly correlated, as NiV infected cells produce
substantially lower amount of C protein compare to the N protein
[15]. We were able to narrow the infection of the CD6+
lymphocytes to CD42CD8+ and CD4+CD8+ T lymphocytes
using triple staining for NiV antigen, CD8 marker, and CD4
marker (Figure 4): T cells gated for CD8+ and NiV antigen
staining had high percentage of cells with positive staining for
CD8+ and NiV (Figure 4.A). In contrast, T cells gated for CD4+
Figure 2. Replication of NiV in the individual subpopulations of PBMC. Sorted cells were inoculated with NiV in three independent
experiments. Total of 10
5cells per subpopulation were inoculated with 10
4 PFU of NiV in one 1 ml volume. The infectivity in cell supernatants was
determined by plaque titration on Vero 76 cells. Fig. 2.A Comparison of virus yield from stimulated and non-stimulated PBMC subpopulations at
48 hrs post inoculation. Black filled columns represent mean of pfu/ml in supernatant collected from non-stimulated cells, the grey filled columns
represent mean of pfu/ml in supernatant collected from stimulated lymphocytes or monocytes. Purity of the individual cell preparations was in the
following range: B cells - 75 to 85%, CD6+ T cells - 90 to 95%, CD4+ T cells - 85%, CD3+CD8+ T cells - 95%, NK cells – 80 to 85%, monocytes - close to
100%. Fig. 2.B Presence of genomic RNA at indicated time points post inoculation in cell lysates from monocytes inoculated with live NiV (solid line)
or with gamma-irradiated NiV (dashed line). Fig. 2.C NiV yield in supernatants of sorted T lymphocytes at 24 hrs post inoculation. Fig. 2.D Detection
of infectivity in supernatant harvested from monocytes at 24 and 48 hrs post inoculation with NiV (gray columns), and detection of viral RNA in cells
inoculated with live virus (solid black line) or with gamma-irradiated NiV (black dashed line).
doi:10.1371/journal.pone.0030855.g002
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positive for both, CD4+, and NiV antigen (Figure 4.B). Analysis
of cells positively stained for CD8+ and NiV antigen indicated that
only low percentage (about 10%) was also positive for CD4 marker
(Figure 4.C). Further analysis of cells positively stained for CD4+
and NiV antigen indicated that they were all positive for CD8
(Figure 4.D) marker. CD4+CD82 cells, and CD42CD82 cells
appeared to be non-permissive to NiV infection.
Based on the cell culture images, NiV infection appeared to
activate the T lymphocytes (Figure 5.A–D). Generally, formation
of the cell clusters is considered to be a phenotypic characteristic of
activation. To confirm the observation, changes in levels of
selected cytokines were determined by semi-quantitative real-time
RT-PCR in CD6+ cells. Relative levels of mRNA expression of
IL-8, TNF a, IFN a and IFN c are summarized in Figure 5.E.
NiV infected cells slightly (less then one-fold) upregulated
expression of IFN c and IL-8 in non-stimulated cells. Significant
upregulation of IL-8 expression was however observed in
stimulated cells infected with NiV (6 fold). Upregulation of IFN
c and TNF a greater then one-fold was observed in stimulated,
NiV infected cells. On the other hand, infection of lymphocytes
with NiV appeared to down-regulate IFN a mRNA, both in non-
stimulated and stimulated cells, when compared to the constitutive
expression levels of IFN a in non-stimulated T lymphocytes or
PMA/ionomycin activated T cells, respectively.
Effect of NiV infection in vitro on PBMC
Effect of NiV infection on lymphocyte population frequencies
was studied in the context of PBMC to approximate the in vivo
situation, allowing for interaction (cell cross-talk) of several cell
populations. We were able to follow up the lymphocytes staining
for CD4 or CD8 marker (Figure 1.B). At 24 hours post infection
the number of CD8+ cells decreased from about 40% to 30% and
down to 20% at 48 hrs post infection, with notable depletion of the
CD8+
hi cytolytic T cells (Figure 6.A–C). Almost no change in
percentage of the CD4+ population was observed at 24 hrs post
inoculation (Figure 6. E), while apparent decrease in CD4+ was
observed at 48 hrs post infection (Figure 6. F). The drop in
CD4+ cells could be attributed to the decrease in CD4+CD8+ cells
(mostly memory helper T cells), however it cannot be excluded
that the significant drop at 48 hrs was due to bystander cell death
of the CD4+CD82 cells, considering the in vivo data below.
Effect of NiV infection in vivo on PBMC
Low levels of NiV RNA were detected in PBMC from 2 to 7
days post inoculation by real-time RT-PCR targeting the N gene,
corresponding with previously published data on low level of NiV
detection in serum, PBMC or whole blood in swine [7,9,10].
Although it was difficult to detect the virus in peripheral blood of
NiV infected piglets by flow cytometry, and total white blood cell
count was considered to be within the normal range (data not
shown), an effect on population frequencies of lymphocytes was
observed using double staining for CD4 and CD8 surface markers.
At two days post inoculation a significant drop (p.0.05) in
CD42CD8+ lymphocytes was observed in PBMC collected from
all 6 infected pigs compared to 4 control animals (Figure 7.A). At
the same time point, the CD4+CD82 population circulating in
peripheral blood increased significantly (p.0.05) when evaluating
all infected piglets versus negative control pigs (Figure 7.B). At
4 dpi, both subpopulations returned close to basal level. The
population frequency of double positive (CD4+CD8+) T cells did
not change substantially compared to non-infected pigs. Low
gradual decrease following the inoculation was statistically
significant (p,0.05) when compared to control animals and the
pre-infection status, but may not have a biological significance
(Figure 7.C).
Interesting trends appeared in population frequencies for piglets
which had to be euthanized during the first week post inoculation
compared to piglets which survived past 7 dpi, and were
euthanized at 28 dpi (end of the study). In piglets requiring early
euthanasia, the CD42CD8+ T cells dropped again at day 6/7, in
contrast to the survivors, where the CD42CD8+ T cells returned
to pre-infection levels (Figure 8.A). Dramatic difference in
population frequency of the CD4+CD82 lymphocytes was
observed between survivors and non-survivors. While there was
a significant increase of CD4+CD82 T helper cells in survivors at
2 dpi, returning to normal by 7 dpi, piglets which had to be
euthanized had no upregulation of CD4+CD82 T cells, and the
population frequency continued to decrease until the end point at
7 dpi (Figure 8 B).
Discussion
We have previously determined that monocytes and a subset of
lymphocytes had internal staining for NiV antigen within the
infected PBMC [10].The experimental work presented in this
manuscript confirmed that NiV can productively infect porcine
peripheral blood monocytes. Increased levels of NiV genomic
RNA were detected in infected monocytes at 48 hrs post infection,
while no viral RNA was detected in cells inoculated with gamma-
irradiated NiV. Interestingly the amount of genomic RNA
decreased in the infected monocytes at 24 hrs post inoculation,
Table 1. Detection of mRNA expression of porcine ephrin-B2 in NiV inoculated and/or activated monocytes and enriched
lymphocytes 48 hrs post inoculation.
Cell Subsets Untreated cells PMA/ionomycin treated cells NiV inoculated cells
PMA/ionomycin treated, NiV
inoculated cells
Monocytes 2 ++ +
CD6+ T cells ++ ++
CD3+CD8+ T cells + N/D + N/D
CD4+ T cells + N/D + N/D
CD21+ B cells 2 + 2 +
CD16+ NK cells 2 ++ +
The (+) indicates mRNA of ephrin-B2 was detected. The (2) indicates mRNA of ephrin -B2 was undetectable. The (N/D) indicates that ephrin-B2 was not determined for
this cell population.
doi:10.1371/journal.pone.0030855.t001
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inoculation. Correspondingly, no infectivity was detected in the
supernatants harvested from the cells at 24 hrs post inoculation,
and relatively high virus yield was obtained at 48 hrs post
infection. The dynamics of NiV replicaiton in monocytes would
indicate that majority of the virus is phagocytosed, and only small
proportion of the virus is internalized in an alternative way
allowing replication.
Here we determined that the NK cells (also carrying the CD8+
marker) and the CD8+ subset of T lymphocytes were permissive to
NiV, thus confirming the hypothesis of cell associated viremia
during NiV infection in the swine host. The level of NiV viremia
detected in the peripheral blood was low but comparable to
previously published work in pigs and other species [7,9,16]. This
phenomenon is not exceptional for paramyxoviruses, and was
observed e.g. for measles virus in humans [17]. The low viremia
somewhat reflects the type of cells infected in the swine host, where
monocytes and NK cells altogether represent between 5–15% of
PBMC, and the majority of CD8+ cells home into the lymph
nodes via lymphatic system [18]. The permissiveness of lympho-
cytes and monocytes to NiV infection appears to be species
specific. Recently Mathieu et al. [19] reported that although
leukocytes likely contribute to viremia in humans and hamsters,
NiV does not replicate in them, and the cells serve merely as
mechanic transporters.
Infection of different subpopulations of PBMC did not appear
to be entirely dependent on pre-existing expression of ephrin-B2, a
primary receptor for NiV [20,21]. Resting monocytes and NK
cells did not have detectable levels of ephrin-B2 mRNA, but
upregulated the ephrin-B2 mRNA following stimulation and/or
NiV inoculation. Based on literature, monocytes express the
alternative ephrin-B3 receptor for NiV [22], sufficient for the
initial infection. Mechanism of the initial infection of NK cells with
NiV is not clear at this moment, as there are no reports on ephrin-
B3 expression (or lack of thereof) in NK cells. However, since the
NK cells preparation contained up to 25% of other cells
Figure 3. Intracellular staining for NiV nucleocapsid N or non-structural C protein in T cells. The cells were sorted based on the presence
of CD4, CD6 or CD3CD8 markers, and infected with NiV at 0.1 moi. Representative flow cytometry histograms were selected from three independent
experiments. Fig. 3.A Lack of intracellular staining for NiV non-structural C protein in CD4+ T cells at 24 hrs post inoculation. Fig. 3.B Intracellular
staining for NiV C protein in CD3+CD8+ T cells at 24 hrs post inoculation. At 48 hrs post inoculation/infection about 30% of the CD3+CD8+ stained
internally for the NiV C protein (Fig. 3.D), confirmed by about 30% of CD6+ T cells stained internally for the NiV nucleocapsid N protein (Fig. 3.C).
doi:10.1371/journal.pone.0030855.g003
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proinflammatory cytokines [23] likely stimulated ephrin-B2
expression on the NK cells, and rendered them permissive to
NiV. While all CD6+ T lymphocytes expressed ephrin-B2, only
the ones expressing CD8 marker were permissive to NiV. Further
investigation of this phenomenon could lead to elucidation of the
role of CD8 marker in the permissiveness of porcine immune cells
to NiV or identification of important cellular factors involved in
block of NiV replication block in the CD6+ cells lacking the CD8
marker.
Infection of the immune cells can modulate the immune
response by down regulation of specific cell populations due to
virus replication followed by cell death or due to release of
cytokines with subsequent bystander death of susceptible cells. In
the context of in vitro infected PBMC, the CD8+
hi T cells were the
most affected subset of cells already at 24 hrs post inoculation with
almost complete elimination of this population at 48 hrs post
infection, consistent with these cells being permissive to NiV.
CD42CD8+
hi T cells were characterized in pigs as cytotoxic T
cells and their decrease would have an effect on clearance of virus
infected cells [18]. We have observed decrease in CD42CD8+ cell
population frequency also in vivo at 2 dpi, however it remains to be
determined whether those were NK cells, cd T cells or cytotoxic T
cells to offer any comments on the in vivo significance.
A decrease in CD4+CD82 T helper cells, observed in vitro,
would influence development of humoral immunity. Interestingly,
the work with in vivo NiV infected PBMC confirmed the dramatic
decrease in population frequency of CD4+CD82 T cells in piglets
which succumbed to NiV infection, while values for surviving
piglets indicated that the CD4+CD82 T cell subset expanded
following the infection, corresponding with functional humoral
response. Although the data are limited, they highlight previous
findings indicating that the development of humoral immunity is
critical factor in protective immune response to NiV [24]. In
surviving animals, the production of antibodies is not considered
impaired, but may be somewhat delayed compared to develop-
ment of antibodies against swine influenza or Hendra virus
[10,25]. It remains to be determined whether drop in
CD4+CD82 T cell population can be used to predict the
outcome of NiV infection in pigs.
Additional work is warranted to understand the role of NK cells,
monocytes and plasmacytoid dendritic cells in the pathogenesis
and development or modulation of immune response to NiV,
which decides the outcome of the NiV infection or the secondary
bacterial infections. In summary, it appears that the focus of
further studies has to shift to innate immune response, as the
critical aspect in the development of adaptive immune response.
This is also supported by our finding of down-regulation of IFN a
Figure 4. NiV infected CD6+ T cells triple stained for CD4 and CD8 markers, and NiV antigen. Dot plot of flow cytometry analysis of NiV
infected CD6+ T cells, triple stained with monoclonal antibodies against CD4 and CD8 markers, and NiV polyclonal guinea pig antiserum 24 hrs post
infection. T cells gated for CD8+ and NiV antigen (Fig. 4.A). T cells gated for CD4+ and NiV staining (Fig. 4.B). Analysis of cells positively stained for
CD8+ and NiV antigen indicated that only low percentage (about 10%) was also positive for CD4 marker (Fig. 4.C). Analysis of cells positively stained
for CD4+ and NiV antigen indicated that they were all positive for CD8 (Fig. 4.D) marker. In summary, cells with CD8 marker, whether CD4+CD8+ or
CD42CD8+ were the ones staining also for NiV antigen.
doi:10.1371/journal.pone.0030855.g004
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While in vitro production of IFN-type I was demonstrated in NiV
infected endothelial cells, the infection down-regulated production
of IFN-type I in several other cell lines of human origin, including
neuronal M17 cells [26,27]. Block of IFN a production by NiV
infected lymphocytes, and possibly other immune cells – such as
plasmacytoid dendritic cells or dendritic cells at the site of infection
may have significant impact on immune response activation and
regulation, and contribute to disease progression/pathogenesis in
NiV infected host [28].
Our main interest was to better understand the role of
peripheral immune blood cells in the viremic spread of NiV
Figure 5. Stimulation of T cells with PMA/ionomycin and/or NiV infection. Figs. 5.A–5.D illustrate changes in cell appearance of the CD6+
T cells after 18 hrs post infection with NiV at 0.1 moi. Formation of cell clusters in NiV infected cells suggests that the infection stimulates T
lymphocytes. Appearance of non-stimulated T cells (Fig. 5.A) in comparison to NiV infected T cells (Fig. 5.B) and the PMA/ionomycin stimulated
cells (Fig. 5.C). NiV infected PMA/ionomycin activated T cells (Fig. 5.D). Fig. 5.E Cytokine RNA profiles were determined 48 hrs post incubation/
infection by quantitative RT-PCR. Gray columns represent ratio of PMA/ionomycin activated cells and non-stimulated T cells; white columns represent
ratio of NiV infected cells compare to non-stimulated cells; black columns represent ratio of infected PMA/ionomycin activated cells compared to
PMA/ionomycin activated T cells.
doi:10.1371/journal.pone.0030855.g005
Nipah Virus Infects Porcine Immune Cells
PLoS ONE | www.plosone.org 7 January 2012 | Volume 7 | Issue 1 | e30855Figure 6. Changes in population frequencies of CD8+ and CD4+ cells following NiV in vitro inoculation of PBMC. Fig. 6.A PBMC control
after 24 hrs incubation stained for CD8 marker. Thin arrow on top of the figure indicates CD8 ab
lo T cells. The highest intensity peak corresponds to
CD8 ab
hi T cells (cytolytic T cells) indicated by the bold arrow. Fig. 6.B NiV infected PBMC stained for CD8 marker at 24 hrs post inoculation. Fig. 6.C
At 48 hrs post inoculation, the peak corresponding with CD8 ab
hi T cells was absent, and the proportion of CD8+ cells decreased from 40% to about
20%. Fig. 6.D PBMC control stained for the CD4 marker after 24 hrs incubation. Fig. 6.E Cells inoculated with NiV stained at 24 hrs post inoculation
for CD4 marker. Fig. 6.F Decrease in CD4+ cells from 20% in the control uninfected PBMC to about 10% at 48 hrs post inoculation with NiV.
doi:10.1371/journal.pone.0030855.g006
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Identification of the CD3+CD6+CD8+ T lymphocytes, as cells
productively infected by NiV, and thus actively contributing to
viremia was of a special interest. CD6 marker is a strong ligand for
the activated leukocyte cell adhesion molecule (ALCAM - CD166)
expressed on the microvascular endothelium of the blood brain
barrier (BBB), and which is upregulated during the inflammation
[29]. The ALCAM is also expressed on the microvascular
endothelial cells of the blood-air barrier in lung [30]. Conse-
quently, dissemination of NiV within the host by the
CD3+CD6+CD8+ cells would be preferentially targeted to small
blood vessels in these two organs. Infection and vasculitis were
described in small blood vessels in several hosts, but not in the
larger vessels [11], consistent with this hypothesis.
Based on previous work of our group, reports in the literature,
and findings reported in this manuscript, we are proposing more
detailed mechanism for the NiV neuroinvasion in swine host
following nasal inoculation. Figure 9 summarizes the events in
the vicinity of a small blood vessel.
The virus gains access to the brain directly from the nasal cavity
by infecting naked nerve endings (cilia) of the olfactory receptor
cells (neurons) located in the mucosa of the olfactory epithelium,
and the infection moves in a retrograde direction into the brain. In
addition, infection of the nasal respiratory epithelium and of the
basal cells of the olfactory epithelium leads to infection of the
trigeminal nerve endings, and proceeds through the trigeminal
ganglion into the brain. Viral antigen was detected in neurons,
oligodendrocytes, astrocytes and microglia [9] with the later three
Figure 7. T cell subpopulation frequencies in NiV infected pigs
during the acute phase of the infection. Changes in CD4D8 cell
subpopulation frequencies in PBMC of pigs infected with NiV based on
flow cytometry analysis. The values obtained at 0 dpi were arbitrarily
set at 50%. The data (mean and standard error) are based on six
infected (solid line) and 4 control (dashed line) animals. Notably,
significant changes with opposite trends were observed for CD42CD8+
T cells (Fig. 7.A), and CD4+ CD82 T cells (Fig. 7.B). The changes in
CD4+CD8+ T cell frequency, although statistically significant, were only
minor, perhaps with slight decline toward the 7 dpi in the infected
piglets compared to the controls (Fig. 7.C).
doi:10.1371/journal.pone.0030855.g007
Figure 8. Comparison of T cell subpopulations between pigs
that died during acute infection versus survivors. The differences
in CD4+ and CD8+ cell subpopulations during the acute infection with
NiV up to 7 dpi. Values, based on flow cytometry analysis, were
arbitrarily set as 50% at 0 dpi. The solid line represents piglets that died
at 7 dpi, the dashed line represents the survivors. Standard Error is
represented as error bars for 2 pigs per each group/mean value.
Survivors had significantly higher values for the CD42CD8+ (Fig. 8.A)
at 7 dpi compare to the piglets which died at that day. Marked
difference was observed for the CD4+CD82 T lymphocytes (Fig. 8.B).
The down-trend starting almost immediately post infection for this cell
subpopulation in pigs that died due to NiV infection was especially
pronounced. In contrast, there was an up-regulation of CD4+CD82 T
helper cells at 2 dpi in the survivors.
doi:10.1371/journal.pone.0030855.g008
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at the very early stage. Astrocytes (possibly participating in
formation of BBB) and microglia being in direct physical contact
with capillaries transmit the virus to the endothelial cells. NiV
infected endothelial cells produce IL-8 beside other inflammatory
cytokines [27] which would recruit T-lymphocytes and monocytes.
In our current work, the T lymphocytes also produced IL-8 upon
infection, and would be likely contributing to the chemotaxis. In
addition, neurons, astrocytes and microglia coordinate activation
and regulation of local inflammatory reactions during infection,
including release of cytokines and recruitment of monocytes and
lymphocytes from circulation [31]. From the recruited cells, the
CD6+ cells would be the ones most strongly adhering to the
microvascular endothelial cells, forming transmigration complexes
and moving into the brain parenchyma [29]. This interaction
could lead to infection of CD6+CD8+ lymphocytes by the
microvascular endothelium at the point of crossing the BBB.
Alternatively, the endothelial cells can become infected by
lymphocytes already replicating the virus, and attracted to the
capillaries due to signalling by astrocytes or microglia. Lympho-
cytes were identified based on morphology as one of the antigen
positive infiltrating cells associated with vasculitis in the brain
[9,14]. Beside the CD6+CD8+ lymphocytes, monocytes and NK
cells can also transmigrate into the brain via weaker ALCAM -
ALCAM interaction [29,32]. At this point, NiV would start the
viremia associated invasion of brain by crossing of the BBB from
blood. Once the microvascular endothelial cells become infected,
the cell free NiV in plasma may be able to cross the BBB as well
[33].
The finding that a subtype of the T cells carrying CD6 surface
marker contribute to viremia in NiV infected host would provide
an explanation as to why the virus has a strong tropism for the
microvascular endothelial cell of the blood-air and the blood-brain
barrier, providing better understanding of the pathogenesis of NiV
in general.
Materials and Methods
Viruses
Nipah virus re-isolated at NCFAD from pigs infected with
human isolate (kindly provided by T. Ksiazek and P. Rollin, CDC,
Atlanta) was used for animal inoculation. The in vitro work was
done initially in parallel with both, the NCFAD swine isolate and
the CDC human isolate (passage 5 in Vero 76 cells).
Virus plaque titration
Vero 76 cells were grown to 100% confluency in 6 well plates
(Costar, Corning Inc. Corning, NY). The cells were washed, and
400 ml of samples serially diluted from 10
21 to 10
24 in DMEM
were added to duplicate wells. Inoculum was removed after one
hour incubation, and replaced with 1.5 ml of 2% carboxymethy-
cellulose (Sigma-Aldrich, Oakville, ON) in DMEM/2% FBS
overlay. After 48 hrs incubation period, cells were fixed by the
addition of 10% PBS buffered formalin (Fisher Scientific, Ottawa,
ON, CA), and stained with crystal violet (0.1% w/v crystal violet
in H2O). The titre of the virus was determined as plaque forming
units per ml (PFU/ml).
Cells
Vero 76 cells (African green monkey kidney, epithelial) (ATCC)
were cultured in Dulbecco’s Modified Eagles Medium (DMEM),
supplemented with 10% fetal bovine serum (FBS) (Wisent Inc., St.
Bruno, Que, CA). IPAM (immortalized porcine alveolar macro-
phage) cells 3D4/31 grown in RPMI 1640 media supplemented
with L-glutamine and 10% FBS were used as positive control for
intracellular detection of NiV [34].
Figure 9. Proposed microvascular component of brain invasion
by NiV in swine. Fig.9.A. NiV invasion of the central nervous system
(CNS) initiated in the nasal cavity leads to virus spread into the brain via
neurons [1]. NiV infects cells in contact with neurons: oligodendrocytes,
astrocytes and microglia [2]. Astrocytes and microglia are in a direct
contact with microvascular endothelial cells (MEC), allowing for direct
NiV iter-cellular transmission and infection of the MEC [3]. Infected
astrocytes, microglia and MEC recruit leukocytes by release of cytokines
(blue arrows). From the incoming leukocytes, the CD6+ T cells can firmly
attach to the MEC via the CD6-CD166/ALCAM interaction [4], form
transmigration cup, and translocate into the brain parenchyma. (The NK
cells and monocytes have low expression of the ALCAM on their
surface, and can also transmigrate into the brain. Since the ALCAM-
ALCAM interaction is weaker then CD6-ALCAM one, this may be a later
event.) The translocating leukocytes can get infected during the
transmigration due to intimate contact with NiV infected MEC [5], and
spread the virus to the parenchymal cells in the brain [6], thus initiating
the CNS invasion via BBB. Fig. 9.B. Alternatively, the recruited
lymphocytes can be already infected with NiV. By forming the
transmigration cap [4], they can during transmigration infect the MEC
[7], spreading subsequently the virus to the in-contact astrocytes and
microglia [8], and/or after transmigration across the BBB infect
additional parenchymal cells [6]. This mechanism initiates the CNS
infection, due to the virus crossing the BBB, and can also apply to
invasion of the brain by NiV in other hosts then pigs. Gray star - neuron,
blue star - astrocyte, green circle - oligodendrocytes, yellow star -
microglia, small brown stars with yellow center - NiV, dark red ovals
adjacent to each other - MEC forming the BBB, green dots - schematic
representation of the ALCAM, light centered reddish ovals - T
lymphocytes with CD6+ markers (dark brown dots), blue arrows -
transmigration of leukocytes across the BBB, black arrows - NiV spread.
doi:10.1371/journal.pone.0030855.g009
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studies were harvested from four pigs in the age group 10–15
weeks and six 40 weeks old pigs (Landrace cross) using cell
preparation tubes, and following the protocol recommended by
the manufacturer (Becton Dickinson, Oakville, ON, CA). The
PBMC were resuspended in RPMI supplemented with 10% FBS,
10 mM Hepes, and 100 IU penicillin/100 mg/ml streptomycin
(Wisent).
In the in vivo studies, PBMC were harvested as described above
from nine piglets 4–6 weeks of age infected intranasally with
2.5610
5 PFU of NiV per animal. The PBMC were harvested
under BSL4 conditions for the cell analysis prior to the
inoculation, and on days 2–7 post inoculation. The blood from
four control pigs was collected at the corresponding time points.
Ethics statement: The collection of blood from Nipah virus
infected piglets was included as a component of the AUD ID#:C -
10-002 (Production of positive and negative pig samples for the
evaluation of diagnostic tests for Nipah virus infection). The
collection of non-infected blood samples was included as a
component of the AUD ID#: C-10-002, AUD ID#: C-09-002
(Ebola virus infection in pigs), AUD ID#: C-11-004 (Age
sensitivity of pigs to Ebola virus and interspecies transmission),
AUD ID#: C-09-011 (Novel H1N1 2009 Influenza transmission
studies in swine). The above studies were approved by the Animal
Care Committee of the Canadian Science Centre for Human and
Animal Health. The collection of blood samples from the older
pigs followed policy No. 1404, permit No. S09-008://, approved
by the Animal Care Committee of the University of Manitoba. All
animal manipulations strictly followed the guidelines of the
Canadian Council on Animal Care.
In vitro infection studies in subpopulations of PBMC
Cell separation into individual subpopulations of
PBMC. Monocytes in the PBMC preparation were allowed to
adhere onto 12 well plates (Costar) by overnight incubation at
37uC in a 5% CO2 incubator. The non-adherent cells were
removed by light washing with PBS, pelleted by centrifugation at
300 g for 10 minutes prior to sorting by positive selection based on
CD6+, CD16+, and CD21+ expression (Figure 1A). Cells were
labelled with mouse monoclonal anti-human CD21 (diluted 1:100)
(IgG1, AbD SeroTec, Raleigh, NC) antibody to obtain B
lymphocytes, or by mouse monoclonal anti- porcine CD16
(1:100) (IgG1,AbD SeroTec) antibody to obtain NK cells, or
with CD6 (1:100) (IgG2a, BD Pharmingen, San Diego, CA)
antibody to obtain T lymphocytes, and separated using
paramagnetic microbeads coupled with rat anti-mouse IgG2a/b
or goat anti-mouse IgG1 antibody (Miltenyi Biotech, Auburn,
CA), respectively. Separation was performed in MACS buffer
(phosphate buffered saline, 1% bovine serum albumin (BSA),
0.09% sodium azide) according to Miltenyi Biotech protocols.
Briefly, cells were filtered through the pre-separation filter and
loaded onto a ferric LS column in a magnetic field such that only
labelled cells were retained in the column. Enriched cells were
eluted with MACS buffer at a high flow rate by removing the
magnet, washed twice with 5% FCS/ RPMI media by
centrifugation at 300 g for 10 min, and plated onto12 well
plates in the same medium.
Non-adherent cells were also used for separation of cells based
on the expression of CD4 and CD8 markers. Cells were either
selected for the CD4 marker using mouse monoclonal antibodies
(mAb) diluted 1:100 (IgG2bk, BD Pharmingen) or pre-selected for
the CD3 marker using mAb against this marker diluted 1:100
(IgG2ak, BD Pharmingen), followed by the CD8+ selection by
mAb diluted 1:100 (IgG2ak, BD Pharmingen). All separations
were done using paramagnetic microbeads coupled with goat anti-
mouse IgG1 (Miltenyi Biotech, Auburn, CA) as described above.
Before plating the cells, viability was determined by trypan blue
exclusion method. Purity of recovered cells was determined by
cytometric analysis of labelled cells using secondary goat anti-
mouse Alexa 488 IgG1 (H&L) antibodies (Molecular Probes,
Invitrogen, Burlington, ON, CA).
NiV inoculation of sorted cells
The separated monocytes, CD21+, CD16+, CD6+,
CD3+CD8+ and CD4+ cells were infected with NiV at 0.1 moi
for 1 hr at 37uC, 5% CO2. The input cell number for separated
cells was 10
5 cells/well. The non-adherent cells were washed twice
by centrifugation at 300 g for 10 min following the virus
adsorption, and resuspended in the RPMI supplemented with
2.5% FBS, plated onto 12-well plates in 500 ml volumes, and
incubated for 24 or 48 hrs at 37uC, 5% CO2. The monocytes were
also washed twice prior to adding the same medium as for the
lymphocytes. Stimulated cells were pre-treated for 1 hr prior to
addition of NiV by ionomycin 430 ng/ml (Sigma - Aldrich,
Oakville, ON, CA) and phorbol 12-myristate 13-acetate (PMA)
7 ng/ml (Sigma B Aldrich) in RPMI media. The incubation
medium for the activated enriched cells was also supplemented
with PMA/ionomycin. Supernatant and cells were harvested at
24 hrs and/or 48 hrs, depending on cell population, and plaque
titrated on Vero 76 cells, using protocol described in 2.2.
In addition, adhered monocytes were trypsinized trypsinized
with 0.25% trypsin/EDTA (Wisent) for 15 min at 37
NC, 5% CO2,
let to recover for 2 hrs at 4uC, and then inoculated in suspension
either with NiV at 0.1 moi or with NiV gamma-irradiated by 5
MRADs at a dilution corresponding to 0.1 moi for 1 h at 37
NC,
5% CO2. Following the incubation, cells were washed three times
with PBS by centrifugation at 600 g for 5 min. Following the third
wash, cells were resuspended in the RPMI/10% FCS, plated onto
12-well plates in 1 ml volumes of 10
5 cells/well and incubated for
1 h, 24 and 48 hrs at 37
NC, 5% CO2. Supernants and cells were
collected at each time point. The supernatants were assayed for
infectivity by plaque assay. The cells were trypsinized as described
above, washed and collected by centrifugation. The pellets were
used for detection of NiV genomic RNA, as described below.
Intracellular staining for NiV antigen
CD6+ enriched T cells infected with NiV were stained
intracellularly for NiV N antigen 48 hrs post infection using
following protocol: The cells were fixed with 100 ml of BD Perm/
Wash Cytofix/Cytoperm solution (BD Pharmigen) for 30 min at
4uC, washed twice, followed by addition of 1:50 diluted mouse
monoclonal anti-N antibody. After incubation on ice for 30 min,
the cells were washed twice with BD Perm /Wash and secondary
antibody was added. Anti-mouse Alexa 488 IgG diluted 1:1000
and incubated with the cells in dark at 4uC for 30 min, washed
twice with BD Perm/Wash. The cells were fixed in 4%
formaldehyde for 24 hrs in order to remove them from the
BSL4, and resuspended in 500 ml of MACS buffer for flow
cytometry analysis.
The NiV infected CD6+ lymphocytes were also triple stained
for the CD4, CD8 markers as described above, followed by
permeabilization of the cells and staining for the NiV antigen using
1:100 diluted guinea-pig polyclonal NiV antiserum and anti-
guinea pig Alexa IgG 594 as secondary antibody, diluted 1:1000.
The separated CD4+ cells, and the CD3+CD8+ cells infected
with NiV were intracellularly stained with 1:100 diluted rabbit
polyclonal anti-C antibody, kindly provided by Dr. Chieko Kai
(University of Tokyo), followed by secondary anti-rabbit Alexa
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two laser Flow Cytometer (Beckman Coulter). Cell populations of
interest were gated for lymphocytes based on light scatter
characteristics and counted to 10,000 events.
Ephrin-B2 RT-PCR
Total cellular RNA was isolated by TriPure isolation reagent
(Roche Diagnostics Corporation, Indianapolis, IN) as per
manufacturer’s protocol. RNA was heat inactivated for 10 min
at 65uC prior to DNase treatment. RNA was treated with Turbo
DNA Free DNase (Ambion, Austin, TX) according to the
manufacturer’s protocol. DNase treated RNA concentration was
determined using 260/280 nm light absorbance ratio (N-D
spectrometer Nano Drop Technologies). Reverse transcription
was performed using Superscript II kit (Invitrogen). A total of 6 ml
mRNA was added to each RT reaction and incubated for 45 min
at 50uC followed by 72uC for 15 min. Two microliters of cDNA
were added to Hotstart PCR mix (Qiagen, Mississauga, ON, CA)
which included 10 mM of forward and reverse ephrin-B2 primers.
A total 25 ml reaction was incubated for 15 min at 95uC followed
by 35 cycles of (95uC -30 sec, 55uC -45 sec, 72uC -30 sec) and
extension period of 10 min for 72uC. PCR fragments were run on
1.5% agarose gels with a 1 kp ladder (Invitrogen). Forward
(ACCAGGCATAATGAGCCAAC) and reverse (CCTCAGCG-
GATGATAATGT ephrin-B2 primers were designed based on
published porcine sequence (Accession NM0001114286 and
EF682141.1) by using Primer 3 Input 4.0 software.
Real-time semi-quantitative RT-PCR for mRNA cytokine
expression
Total cellular RNA was extracted from enriched lymphocytes by
TriPure isolation reagent (Roche Diagnostics) method. Reverse
transcription was performed using random hexamer primers, and
employing Quanitect kit (Qiagen). Ten microliters of 100 ng/ml
samples were added to each RT reaction. After DNase treatment at
42uC for 4 min, RNA was reverse transcribed at 42uC for 20 min,
and the reaction was terminated by 2 min incubation at 72uC. The
real time PCR was performed using Taqman 3100 and Quantitech
SYBR green PCR kit (Qiagen). Two microlitres of cDNA were
added to a total volume of 25 ml. Real time PCR reaction had the
following conditions for all primer sets (300 nM): 95uC for 15 min,
followed by 41 cycles of (95uC - 15 sec, 55uC - 30 sec, 72uC-
30 sec). Primers used for amplification were following:
IL-8 (TTCTGCAGCTCTCTGTGAGGC/ GGTGGAAAG-
GTGTGGAATGC) [35],
TNF a (CCCCCAGAAGGAAGAGTTTC/CGGGCTTATC-
TGAGGTTTGA) [35],
IFN a (TCAGCTGCAATGCCATCTG/AGGGAGAGATT-
CTCCTCATTTGTG) [36],
IFN c (TGGTAGCTCTGGGAAACTGAATG/GGCTTTG-
CGCTGGATCTG) [36], and cyclophilin (TAACCCCACC-
GTCTTCTT/TGCCATCCAACCACTCAG).
Cyclophilin primers were designed by Primer 3 Input 4.0 and
porcine cyclophilin sequences obtained from BLAST search
database. Dissociation curve and controls were added to each
reaction. The real time RT-PCR reactions were performed in
duplicates. A relative expression ratio of cytokine gene was
calculated 2
2
‘‘Ct according to Livak and Schmittgen [37], and
using cyclophilin mRNA as reference.
Real-time RT-PCR for NiV RNA detection
Real-time RT-PCR targeting NiV N gene was performed as
described previously by Guillaime et al. [38]. All cultures (PBMC,
enriched T cells, enriched B cells, enriched NK cells, IPAM and
VERO 76 cells) used in the in vitro study for NiV inoculation were
verified for NiV infection by NiV N-gene RT-PCR. In the in vivo
study, detection of NiV RNA was from a 100 ml of approximately
10
6 cell/ml of PBMC from both, control and inoculated pigs.
Detection of NiV genomic RNA
Total cellular RNA was isolated by TriPure isolation reagent
(Roche Diagnostics) as per manufacturer’s protocol. The RNA
concentration and integrity was determined prior to the RT
reaction. The first strand cDNA synthesis reaction was catalyzed
by Superscript II reverse transcriptase (Invitrogen) with random
hexamer primers. A total of 5 ml of RNA (200 ng/ml) was added to
each RT reaction and incubated for 42 min at 50uC followed by
72uC for 15 min prior to amplification of target cDNA. RNase H
was added to each reaction. Ten percent of cDNA synthesized in
the first strand reaction was amplified on Corbett Research
RotorGene RG-3000 real time system (Montreal Biotech Inc,
Dorval, QC). The PCR reactions were performed with Quantitect
RT-PCR kit (Qiagen), using same probe and the primers as for the
NiV N-gene RT-PCR (Weingartl et al., 2005). Detection of
cyclophilin mRNA was used for each sample tested as described in
our protocol for mRNA cytokine expression to allow for sample
comparison.
Flow cytometry analysis of PBMC in vitro inoculated with
NiV
Inoculation of PBMC with NiV. Input of PBMC per well
was 10
6 cells, and the cells were infected with 1 MOI of NiV, using
protocols described for subpopulation of PBMC in previous
section. The cells were harvested for analysis at 24 and 48 hrs post
infection by collection from the plates and centrifugation.
Analysis of population frequencies. Phenotypic analysis of
PBMC subsets was performed using the mAb anti-CD4 (PE
conjugated, IgG2bk, BD Pharmingen), and anti-CD8 (PE
conjugated IgG2ak, BD Pharmingen), and the analysis was done
on separate cell preparations. The PBMC were diluted to10
6 cells/
ml, washed with MACS buffer, and pelleted by centrifugation at
3006 g for 10 min. After the supernatants were discarded, the
remaining cell pellets were resuspended with 1:100 dilution of
mAb against CD4+ or CD8+, or isotype controls and incubated
on ice for 30 min in the dark. The cells were washed twice times
with 1 ml of MACS buffer, and fixed in MACS buffer with 3.5%
paraformaldehyde before removal from the BSL4, and analyzed
on a two laser Flow Cytometer (Beckman Coulter, Mississauga,
ON, CA). Cell populations of interest were gated based on 10,000
events with light scatter characteristics of lymphocytes. The data
was analyzed using CXP software (Beckman Coulter). Infected
cells incubated without any antibodies, and infected and
uninfected cells incubated with isotype controls were used as
negative control.
Flow cytometry analysis of in vivo infected PBMC
For phenotyping lymphocytes in PBMC by flow cytometry,
both single and double staining was employed to define different
subpopulation. Lymphocytes were first gated from PBMC by size
(FSC) and granularity (SSC). To further distinguish T lympho-
cytes, cells were gated for CD3+ using anti-CD3 (FITC IgG2ak,
BD Pharmingen, diluted 1:100), and the number of events
collected for analysis was 10,000. The following monoclonal
antibodies were used to analyse the population frequencies of T
lymphocytes in PBMC: anti-CD4 (FITC conjugated, IgG2bk, BD
Pharmingen), and anti-CD8 (PE conjugated IgG2ak, BD Phar-
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background controls. Unfixed lymphocytes suspensions were first
filtered by pre-separation filter (Miltenyi Biotech) followed by
incubation with a mixture of two antibodies directed against the
surface molecule of interest. All incubations were done at 4uC for
30 min and washed twice at 600 g for 5 min. All samples were
kept on ice until paraformaldhyde was added after the final wash.
Analysis was on a two laser Flow Cytometer (Beckman Coulter).
The data was analyzed using CXP software (Beckman Coulter).
Statistical Analysis
Data analysis was performed using Graph Pad In Stat version
3.0 (GraphPad software, San Diego, CA). Student t-test was used
for comparison between means of groups. Differences were
considered as significant at P value,0.05.
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